Management of diabetic foot ulcers with a TLC-NOSF wound dressing

Journal of Wound Care

Volumn 21, Issue 3, 2012, Pages 142-147

  Richard, J L ^a   Martini, J ^b   Faraill, M M Bonello ^c   M'Bemba, J ^d   Lepeut, M ^e   Truchetet, F ^f   Ehrler, S ^g   Schuldiner, S ^a   Sauvadet, A ^h   Bohbot, S ^h  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b CHU RANGUEIL   (France)

^c PASTEUR HOSPITAL   (France)

^d HÔTEL DIEU   (France)

^e General Hospital   (France)

^f Beauregard Hospital   (France)

^g Georges Clemenceau Hospital   (France)

^h Laboratoires URGO ^*  (France)

Author keywords

Multicentre clinical trial; Nano oligosaccharide factor; Neuropathic diabetic foot ulcers; Wound dressing

Indexed keywords

CARBOXYMETHYLCELLULOSE; OLIGOSACCHARIDE; PETROLATUM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLLOID; DIABETIC FOOT; DIABETIC NEUROPATHY; FEMALE; HUMAN; HYDROCOLLOID DRESSING; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; MULTICENTER STUDY; PILOT STUDY; TREATMENT OUTCOME;

ADULT; AGED; BANDAGES, HYDROCOLLOID; CARBOXYMETHYLCELLULOSE SODIUM; COLLOIDS; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PETROLATUM; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 84861663536     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2012.21.3.142     Document Type: Article

References (23)

1. Snyder, R.J., Hanft, J.R. Diabetic foot ulcers. Effects on QoL, costs, and mortality and the role of standard wound care and advanced-care therapies. Ostomy Wound Manage. 20209; 55: 11, 28-38.
2. Nabuurs-Franssen, M.H., Huijberts, M.S., Nieuwenhuijzen Kruseman, A.C. et al. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia. 2005; 48: 9, 1906-1910. (Pubitemid 41317847)
3. Jeffcoate, W.J., Price, P., Harding, K.G. Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab Res Rev. 2004; 20: (Suppl. 1), S78-89. (Pubitemid 38714341)
4. Sibbald, R.G., Woo, K.Y. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev. 2008; 224: (Suppl. 1), S25-30. (Pubitemid 351802768)
5. Liu, Y., Min, D., Bolton, T. et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 2009; 32: 1, 117-119.
6. Lobmann, R., Ambrosch, A., Schultz, G. et al. Expression of matrix-metalloproteinases and inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002; 45: 7, 1011-1016. (Pubitemid 34762196)
7. Lobmann, R., Zemlin, C., Motzkau, M. et al. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications. 2006; 20: 5, 329-335. (Pubitemid 44308585)
8. Vin, F.L., Téot, L., Meaume, S. The healing properties of Promogran in venous leg ulcers. J Wound Care. 2002; 11: 9, 335-341.
9. Veves, A., Sheehan, P., Pham, H.T. A randomized controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002; 137: 7, 822-827. (Pubitemid 34743174)
10. Coulomb, B., Couty, L., Fournier, B. et al. A NOSF (nano-oligasaccharide factor) lipido-colloid dressing inhibits MMPs in an in vitro dermal equivalent model. Wound Repair Regen. 2008; 16: 4, A74.
11. Couty, L., Fournier, B., Laurensou, C. et al. A NO SF (nano-oligasaccharide factor) lipido-colloid dressing stimulates MMPs/TIMPs complexes formation leading to MMPs inhibition in an in vitro dermal equivalent model. Wound Repair Regen. 2009; 17: 4, A64.
12. Coulomb, B., Couty, L., Fournier, B. et al. Evaluation of a matrix impregnated with NO SF in an in vitro dermal reconstruction model [article in French]. Journal Plaies Cicatrisations. 2008; 13: 54-57.
13. Schmutz, J.L., Meaume, S., Fays, S. et al. Evaluation of the nano-oligosaccharide factor lipido-colloid matrix, in the local management of venous leg ulcers: Results of a randomized controlled trial. Int Wound J. 2008; 5: 2, 172-182. (Pubitemid 351731669)
14. Feldman, E.L., Stevens, M.J., Thomas, P.K. et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994; 17: 11, 1281-1289. (Pubitemid 24324972)
15. Armstrong, D.G., Lavery, L.A., Harkless, L.B. Validation of a diabetic wound classification system: The contribution of depth, infection and vascular disease to the risk of amputation. Diabetes Care. 1998; 21: 5, 855-859. (Pubitemid 28487086)
16. Margolis, D.J., Kantor, J., Berlin, J.A. Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-Analysis. Diabetes Care. 1999; 22: 5, 692-695. (Pubitemid 29220765)
17. Yager, D.R., Nwomeh, B.C. The proteolytic environment of chronic wounds. Wound Repair Regen. 1999; 7: 6, 433-441. (Pubitemid 30027565)
18. Smiell, J.M., Wieman, T.J., Steed, D.L. et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: A combined analysis of four randomized studies. Wound Repair Regen. 1999; 7: 5, 335-346. (Pubitemid 29523009)
19. Steed, D.L., Diabetic Ulcer Study Group. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg. 1995; 21: 1, 71-78.
20. Embil, J.E., Sibbald, G., Tousignant, J. et al. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcer: An open-label clinical evaluation of efficacy. Wound Repair Regen. 2000; 8: 3, 162-168. (Pubitemid 30421518)
21. Niezgoda, J.A., van Gils, C.C., Frykberg, R.G., Hodde, J.P. Randomized clinical trial comparing OA SIS Wound Matrix to Regranex Gel for diabetic ulcers. Adv Skin Wound Care. 2005; 18: (Pt 1), 258-266.
22. Sheehan, P., Jones, P., Caselli, A. et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003; 26: 6, 1879-1882. (Pubitemid 36929137)
23. Meaume, S., Ourabah, Z., Cartier, H. et al. Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers. J Wound Care. 2005; 14: 7, 329-334.